DALLAS, Aug. 6, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring Nephros Inc. (OTCBB:NEPH). The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.
The investment report on Nephros Inc. (OTCBB:NEPH) should be of particular interest to other medical instruments and supplies providers: Fresenius Medical Care ADS (NYSE:FMS), Pall Corp. (NYSE:PLL), McKesson Corp. (NYSE:MCK) and Cardinal Health Inc. (NYSE:CAH).
It is available at: http://www.stockpreacher.com/n/NEPH
Nephros Inc. (NEPH) is a developer, manufacturer and marketer of proprietary hemodiafiltration product technologies to treatment patients with end-stage renal disease (ESRD), a kidney failure condition. The Company's products address present technology failure to remove various harmful substances called middle molecules, which are left in the blood from existing dialysis methods.
In the report, the analyst notes:
"The United States market for end-stage renal disease dialysis devices is estimated to reach more than $2 billion in 2010, and reach more than $11 billion worldwide. The various devices for filtering blood include hemodialysis and peritoneal dialyzers, hemodialysis machines, access devices, cyclers and catheters.
"The Company's Mid-Dilution Hemodiafiltration fluid management system optimizes renal toxins across the entire mid-molecular spectrum. NEPH's complimentary cost-effective online substitution system eliminates associated costs of earlier diafiltration systems. Hemodiafiltration systems have proved to perform better than Hemodialysis (HD), reducing incidences of carpal tunnel syndrome surgeries by as much as 40% and mortality risks by 35%."
To read the entire report visit: http://www.stockpreacher.com/n/NEPH
StockPreacher.com is a small-cap research and investment commentary provider. StockPreacher.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on StockPreacher, please visit: http://www.stockpreacher.com
StockPreacher.com Disclosure
StockPreacher.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. StockPreacher.com is a Web site wholly-owned by BlueWave Advisors, LLC. Please read our report and visit our Web site, StockPreacher.com, for complete risks and disclosures.
CONTACT: StockPreacher.com
Jeff Bishop
(469)-252-3505
press@beaconequity.com
